Strides Pharma Science Ltd.

BSE: 532531 | NSE: STAR |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE939A01011 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Strides Pharma Strides Pharma Science Ltd. | BSE 928.50 -18.45 (-1.95%) | NSE 929.20 -19.00 (-2.00%) | Trade | Add

BSE Live

Nov 10, 16:01

928.50 -18.45 (-1.95%)

Volume

AVERAGE VOLUME

5-Day

233,671

10-Day

121,391

30-Day

48,252

9,844

Prev. Close

946.95
Open Price

955.90

Bid Price (Qty.)
916.65 (1)
Offer Price (Qty.)
936.00 (10)

NSE Live

Nov 10, 15:59

929.20 -19.00 (-2.00%)

Volume

AVERAGE VOLUME

5-Day

1,401,791

10-Day

1,754,522

30-Day

769,278

338,904

Prev. Close

948.20
Open Price

955.05

Bid Price (Qty.)
929.20 (274)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Strides Pharma Science (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Per Share Ratios
Basic EPS (Rs.)	390.55	-7.76	-22.49	-51.28	29.96
Diluted EPS (Rs.)	390.50	-7.76	-22.49	-51.28	29.92
Cash EPS (Rs.)	411.00	32.87	35.02	-14.53	62.65
Book Value [ExclRevalReserve]/Share (Rs.)	276.88	225.43	238.73	265.39	313.78
Book Value [InclRevalReserve]/Share (Rs.)	276.88	225.43	238.73	265.39	313.78
Revenue from Operations/Share (Rs.)	495.35	440.82	408.45	341.94	369.74
PBDIT/Share (Rs.)	93.48	85.20	57.64	12.46	76.52
PBIT/Share (Rs.)	72.62	61.18	30.70	-13.49	53.52
PBT/Share (Rs.)	52.63	6.40	-0.10	-60.33	41.62
Net Profit/Share (Rs.)	390.14	8.86	8.08	-40.48	39.65
NP After MI And SOA / Share (Rs.)	389.90	-7.68	-22.44	-51.25	29.93
Profitability Ratios
PBDIT Margin (%)	18.87	19.32	14.11	3.64	20.69
PBIT Margin (%)	14.65	13.87	7.51	-3.94	14.47
PBT Margin (%)	10.62	1.45	-0.02	-17.64	11.25
Net Profit Margin (%)	78.76	2.00	1.97	-11.83	10.72
NP After MI And SOA Margin (%)	78.71	-1.74	-5.49	-14.98	8.09
Return on Networth/Equity (%)	140.81	-3.32	-9.23	-19.51	9.66
Return on Capital Employed (%)	19.35	18.99	7.59	-3.39	11.22
Return on Assets (%)	59.40	-1.20	-3.05	-6.59	3.82
Total Debt/Equity (X)	0.70	1.14	1.26	1.18	0.69
Asset Turnover Ratio (%)	0.77	0.65	0.54	0.32	0.33
Liquidity Ratios
Current Ratio (X)	1.20	1.03	1.08	0.99	1.03
Quick Ratio (X)	0.70	0.64	0.70	0.64	0.59
Inventory Turnover Ratio (X)	3.80	1.18	1.24	1.09	1.43
Dividend Payout Ratio (NP) (%)	0.63	-19.18	0.00	0.00	6.67
Dividend Payout Ratio (CP) (%)	0.60	9.02	0.00	0.00	3.77
Earnings Retention Ratio (%)	99.37	119.18	0.00	0.00	93.33
Cash Earnings Retention Ratio (%)	99.40	90.98	0.00	0.00	96.23
Coverage Ratios
Interest Coverage Ratios (%)	3.46	2.49	1.99	0.63	4.57
Interest Coverage Ratios (Post Tax) (%)	3.46	2.49	1.99	0.63	4.57
Valuation Ratios
Enterprise Value (Cr.)	7,859.17	9,361.60	5,003.14	5,740.37	9,337.55
EV/Net Operating Revenue (X)	1.72	2.31	1.36	1.87	2.82
EV/EBITDA (X)	9.12	11.96	9.61	51.31	13.61
MarketCap/Net Operating Revenue (X)	1.35	1.78	0.70	1.01	2.28
Retention Ratios (%)	99.36	119.18	0.00	0.00	93.32
Price/BV (X)	2.42	3.38	1.18	1.32	2.73
Price/Net Operating Revenue	1.35	1.78	0.70	1.01	2.28
Earnings Yield	0.58	-0.01	-0.08	-0.15	0.04